11 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
10 Nov 22
Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
4:29pm
with the closing of the offering, Avenue completed the buyout of a minority shareholder through the acquisition of their shares for $3.0 million.
In November
8-K
rpqo8j 1bqcgi
16 May 22
Entry into a Material Definitive Agreement
4:44pm
8-K
EX-99.1
80x 0ud4vea
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am
8-K
EX-99.1
ry6el2rx8
17 Dec 20
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
9:02am
8-K
EX-99.1
wntbwjexk
13 Oct 20
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
6:10am
8-K
EX-99.1
9pt1 defqoxhuydfkkj
12 Mar 19
Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights
9:16am
- Prev
- 1
- Next